The Next Frontier in Metabolic Health and Weight Management
Understanding the Mechanism of Triple Agonist Therapy The landscape of obesity treatment is undergoing a seismic shift with the emergence of multi-receptor agonists, and Synedica retatrutide represents a pivotal advancement in this domain. Unlike earlier generations of weight-loss medications that targeted single hormonal pathways, retatrutide functions as a triple agonist, simultaneously activating receptors for glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide… Continue reading The Next Frontier in Metabolic Health and Weight Management